Adverse events1,209

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,209

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel + Pembrolizumab + Olaparib	270	452	488
other	Anaemia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel + Pembrolizumab	212	456	344
other	Anaemia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel	205	454	322
other	Leukopenia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel + Pembrolizumab + Olaparib	90	452	201
other	Leukopenia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel + Pembrolizumab	60	456	110
other	Leukopenia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel	60	454	113
other	Neutropenia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel + Pembrolizumab + Olaparib	170	452	437
other	Neutropenia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel + Pembrolizumab	138	456	309
other	Neutropenia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel	147	454	317
other	Thrombocytopenia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel + Pembrolizumab + Olaparib	89	452	180
other	Thrombocytopenia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel + Pembrolizumab	73	456	127
other	Thrombocytopenia	Blood and lymphatic system disorders	Carboplatin + Paclitaxel	72	454	127
other	Hyperthyroidism	Endocrine disorders	Carboplatin + Paclitaxel + Pembrolizumab + Olaparib	33	452	37
other	Hyperthyroidism	Endocrine disorders	Carboplatin + Paclitaxel + Pembrolizumab	44	456	49
other	Hyperthyroidism	Endocrine disorders	Carboplatin + Paclitaxel	23	454	25
other	Hypothyroidism	Endocrine disorders	Carboplatin + Paclitaxel + Pembrolizumab + Olaparib	89	452	107
other	Hypothyroidism	Endocrine disorders	Carboplatin + Paclitaxel + Pembrolizumab	93	456	111
other	Hypothyroidism	Endocrine disorders	Carboplatin + Paclitaxel	42	454	50
other	Abdominal distension	Gastrointestinal disorders	Carboplatin + Paclitaxel + Pembrolizumab + Olaparib	26	452	28
other	Abdominal distension	Gastrointestinal disorders	Carboplatin + Paclitaxel + Pembrolizumab	26	456	28

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03740165/events

API reference For AI assistants

Adverse events1,209

Sources 3

Read this list from software.